Group 1: Earnings Performance - Select Medical reported quarterly earnings of $0.50 per share, exceeding the Zacks Consensus Estimate of $0.36 per share, and up from $0.46 per share a year ago, representing an earnings surprise of 38.89% [1] - The company posted revenues of $1.76 billion for the quarter ended September 2024, surpassing the Zacks Consensus Estimate by 2.30%, compared to $1.67 billion in the same quarter last year [2] - Over the last four quarters, Select Medical has consistently surpassed consensus EPS estimates and revenue estimates [2] Group 2: Stock Performance and Outlook - Select Medical shares have increased approximately 39.8% since the beginning of the year, outperforming the S&P 500's gain of 21.9% [3] - The future stock price movement will largely depend on management's commentary during the earnings call and the earnings outlook [4][6] - The current consensus EPS estimate for the upcoming quarter is $0.31 on revenues of $1.75 billion, and for the current fiscal year, it is $2.03 on revenues of $7.02 billion [7] Group 3: Industry Context - The Medical - HMOs industry, to which Select Medical belongs, is currently ranked in the bottom 18% of over 250 Zacks industries, indicating potential challenges ahead [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which could impact Select Medical's performance [5]
Select Medical (SEM) Q3 Earnings and Revenues Surpass Estimates